Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Potassium Iodide | 3 | 2018 | 14 | 0.460 |
Why?
|
Alkaloids | 1 | 2013 | 192 | 0.400 |
Why?
|
Molecular Conformation | 3 | 2019 | 542 | 0.390 |
Why?
|
Azocines | 1 | 2011 | 20 | 0.380 |
Why?
|
Mesylates | 1 | 2009 | 37 | 0.340 |
Why?
|
Tosyl Compounds | 1 | 2009 | 115 | 0.330 |
Why?
|
Light | 7 | 2019 | 1357 | 0.300 |
Why?
|
Lasers, Gas | 2 | 2022 | 101 | 0.290 |
Why?
|
Photochemotherapy | 4 | 2020 | 832 | 0.290 |
Why?
|
Acinetobacter baumannii | 2 | 2021 | 123 | 0.280 |
Why?
|
Cross-Linking Reagents | 1 | 2009 | 692 | 0.260 |
Why?
|
Gram-Positive Bacteria | 2 | 2016 | 180 | 0.230 |
Why?
|
Photosensitizing Agents | 3 | 2020 | 633 | 0.230 |
Why?
|
Disinfection | 2 | 2016 | 207 | 0.220 |
Why?
|
Thiazines | 2 | 2014 | 38 | 0.220 |
Why?
|
Gram-Negative Bacteria | 2 | 2016 | 276 | 0.220 |
Why?
|
Titanium | 2 | 2016 | 495 | 0.220 |
Why?
|
Models, Molecular | 4 | 2019 | 5443 | 0.210 |
Why?
|
Anti-Infective Agents | 3 | 2019 | 987 | 0.210 |
Why?
|
Protein Folding | 1 | 2007 | 875 | 0.210 |
Why?
|
Fullerenes | 2 | 2019 | 14 | 0.200 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 4 | 2021 | 704 | 0.190 |
Why?
|
Lasers | 2 | 2018 | 952 | 0.180 |
Why?
|
Anti-Bacterial Agents | 6 | 2021 | 7471 | 0.180 |
Why?
|
Skin | 4 | 2022 | 4520 | 0.180 |
Why?
|
Water | 1 | 2007 | 1421 | 0.180 |
Why?
|
Pseudomonas aeruginosa | 3 | 2021 | 1277 | 0.180 |
Why?
|
Palladium | 2 | 2010 | 67 | 0.170 |
Why?
|
Sodium Nitrite | 1 | 2019 | 16 | 0.160 |
Why?
|
Carbapenems | 1 | 2020 | 125 | 0.160 |
Why?
|
Tetracyclines | 1 | 2018 | 64 | 0.160 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1195 | 0.150 |
Why?
|
Microbial Viability | 1 | 2019 | 236 | 0.150 |
Why?
|
Nitrates | 1 | 2019 | 260 | 0.140 |
Why?
|
Molecular Structure | 2 | 2013 | 1889 | 0.140 |
Why?
|
Fluorouracil | 2 | 2022 | 1656 | 0.140 |
Why?
|
Fungi | 2 | 2016 | 346 | 0.140 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2016 | 238 | 0.140 |
Why?
|
Bromides | 1 | 2016 | 21 | 0.130 |
Why?
|
Sodium Compounds | 1 | 2016 | 35 | 0.130 |
Why?
|
Fluorescent Dyes | 2 | 2016 | 1924 | 0.130 |
Why?
|
Carbocyanines | 1 | 2016 | 175 | 0.130 |
Why?
|
Respiratory System Agents | 1 | 2015 | 30 | 0.130 |
Why?
|
Biofilms | 2 | 2021 | 634 | 0.130 |
Why?
|
Skin Diseases, Bacterial | 1 | 2016 | 67 | 0.120 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 57 | 0.120 |
Why?
|
Oxazepines | 1 | 2015 | 22 | 0.120 |
Why?
|
Cell Tracking | 1 | 2016 | 140 | 0.120 |
Why?
|
Barbiturates | 1 | 2015 | 113 | 0.120 |
Why?
|
Porphyrins | 1 | 2016 | 354 | 0.110 |
Why?
|
Catalysis | 3 | 2010 | 769 | 0.110 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2015 | 305 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 2232 | 0.110 |
Why?
|
Phototherapy | 1 | 2016 | 369 | 0.100 |
Why?
|
Drug Delivery Systems | 2 | 2015 | 2238 | 0.100 |
Why?
|
Encephalitis | 1 | 2016 | 441 | 0.100 |
Why?
|
Femoral Vein | 1 | 2012 | 154 | 0.100 |
Why?
|
Cisplatin | 1 | 2018 | 1661 | 0.100 |
Why?
|
Oxazines | 1 | 2014 | 357 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 4 | 2021 | 1965 | 0.090 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 623 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2016 | 2150 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2016 | 752 | 0.090 |
Why?
|
Hydrocarbons, Aromatic | 1 | 2010 | 23 | 0.090 |
Why?
|
Quantum Theory | 1 | 2010 | 69 | 0.090 |
Why?
|
Esters | 1 | 2011 | 212 | 0.090 |
Why?
|
Xylenes | 1 | 2009 | 8 | 0.080 |
Why?
|
Fibrin | 1 | 2012 | 515 | 0.080 |
Why?
|
Iodobenzenes | 1 | 2009 | 23 | 0.080 |
Why?
|
Rotation | 1 | 2011 | 517 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 746 | 0.080 |
Why?
|
Thermodynamics | 2 | 2010 | 594 | 0.080 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2009 | 136 | 0.080 |
Why?
|
Administration, Cutaneous | 3 | 2018 | 716 | 0.080 |
Why?
|
Blood Platelets | 1 | 2019 | 2485 | 0.080 |
Why?
|
Singlet Oxygen | 2 | 2018 | 58 | 0.080 |
Why?
|
Pyrrolidinones | 1 | 2009 | 116 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2611 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2016 | 1836 | 0.080 |
Why?
|
Nicotine | 1 | 2012 | 681 | 0.070 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 998 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2018 | 6241 | 0.070 |
Why?
|
Oligopeptides | 1 | 2012 | 1193 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2422 | 0.070 |
Why?
|
Copper | 1 | 2009 | 368 | 0.070 |
Why?
|
Amides | 1 | 2009 | 452 | 0.070 |
Why?
|
Photochemical Processes | 2 | 2016 | 86 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1977 | 0.070 |
Why?
|
Boronic Acids | 1 | 2009 | 915 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2012 | 825 | 0.060 |
Why?
|
Wound Infection | 2 | 2018 | 244 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2640 | 0.060 |
Why?
|
Drug Synergism | 2 | 2019 | 1765 | 0.060 |
Why?
|
Swine | 3 | 2022 | 5996 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1834 | 0.060 |
Why?
|
Vaccines | 1 | 2012 | 845 | 0.060 |
Why?
|
Bacteria | 3 | 2021 | 2226 | 0.060 |
Why?
|
Hydrogen Peroxide | 2 | 2018 | 742 | 0.060 |
Why?
|
Tyrosine | 2 | 2018 | 1428 | 0.050 |
Why?
|
Animals | 14 | 2022 | 169418 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1318 | 0.050 |
Why?
|
Escherichia coli | 3 | 2019 | 4220 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2018 | 2298 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2016 | 1100 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5797 | 0.050 |
Why?
|
Decontamination | 1 | 2019 | 73 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3939 | 0.040 |
Why?
|
Mice | 8 | 2021 | 82045 | 0.040 |
Why?
|
Structure-Activity Relationship | 2 | 2015 | 3073 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4077 | 0.040 |
Why?
|
Blood Preservation | 1 | 2019 | 169 | 0.040 |
Why?
|
Epinephrine | 1 | 2022 | 795 | 0.040 |
Why?
|
Carboxylic Acids | 1 | 2018 | 91 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2020 | 307 | 0.040 |
Why?
|
Skin Absorption | 1 | 2018 | 96 | 0.040 |
Why?
|
Electron Transport | 1 | 2018 | 211 | 0.040 |
Why?
|
Rolipram | 1 | 2016 | 24 | 0.030 |
Why?
|
Amines | 1 | 2018 | 280 | 0.030 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2016 | 37 | 0.030 |
Why?
|
Doxapram | 1 | 2015 | 4 | 0.030 |
Why?
|
Ligands | 2 | 2015 | 3281 | 0.030 |
Why?
|
Vacuum | 1 | 2015 | 65 | 0.030 |
Why?
|
Benzeneacetamides | 1 | 2015 | 36 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2012 | 4906 | 0.030 |
Why?
|
Candida albicans | 1 | 2018 | 376 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2015 | 110 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13708 | 0.030 |
Why?
|
Kinetics | 2 | 2015 | 6348 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2018 | 524 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2016 | 743 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2015 | 826 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 267 | 0.030 |
Why?
|
Sphingosine | 1 | 2016 | 308 | 0.030 |
Why?
|
Type C Phospholipases | 1 | 2015 | 287 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 732 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2016 | 338 | 0.030 |
Why?
|
Diffusion | 1 | 2015 | 818 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 489 | 0.030 |
Why?
|
COS Cells | 1 | 2015 | 1136 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1543 | 0.020 |
Why?
|
Pressure | 1 | 2015 | 1173 | 0.020 |
Why?
|
Metal Nanoparticles | 1 | 2016 | 406 | 0.020 |
Why?
|
Mutagenesis | 1 | 2015 | 1230 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2016 | 18388 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2014 | 342 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 650 | 0.020 |
Why?
|
Phlebography | 1 | 2012 | 326 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2015 | 1468 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2012 | 379 | 0.020 |
Why?
|
Molecular Weight | 1 | 2012 | 2173 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2010 | 292 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1379 | 0.020 |
Why?
|
HeLa Cells | 1 | 2016 | 3090 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1381 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 612 | 0.020 |
Why?
|
Chlorides | 1 | 2012 | 663 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2030 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1804 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 1998 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6320 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 710 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6030 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3861 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 1775 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22365 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5880 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4294 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3472 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6135 | 0.010 |
Why?
|
Burns | 1 | 2016 | 1887 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5223 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13452 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17647 | 0.010 |
Why?
|
Female | 6 | 2018 | 396943 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15609 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7449 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9526 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19041 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23839 | 0.010 |
Why?
|
Humans | 7 | 2022 | 768451 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11930 | 0.010 |
Why?
|
Immunotherapy | 1 | 2012 | 4728 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2012 | 9066 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40271 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23638 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20762 | 0.000 |
Why?
|
Male | 1 | 2012 | 364781 | 0.000 |
Why?
|
Concepts
(187)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_